Lipoprotein (a)

Where does the atherogenicity reside?

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)131-132
Number of pages2
JournalJournal of Laboratory and Clinical Medicine
Volume139
Issue number3
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Apolipoproteins A
Lipoprotein(a)
Particle Size
Cardiovascular Diseases

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Lipoprotein (a) : Where does the atherogenicity reside? / Berglund, Lars.

In: Journal of Laboratory and Clinical Medicine, Vol. 139, No. 3, 2002, p. 131-132.

Research output: Contribution to journalArticle

@article{f7dc47dc82ca4b678aa0f2d7e0030e81,
title = "Lipoprotein (a): Where does the atherogenicity reside?",
author = "Lars Berglund",
year = "2002",
doi = "10.1067/mlc.2002.121769",
language = "English (US)",
volume = "139",
pages = "131--132",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Lipoprotein (a)

T2 - Where does the atherogenicity reside?

AU - Berglund, Lars

PY - 2002

Y1 - 2002

UR - http://www.scopus.com/inward/record.url?scp=0036010026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036010026&partnerID=8YFLogxK

U2 - 10.1067/mlc.2002.121769

DO - 10.1067/mlc.2002.121769

M3 - Article

VL - 139

SP - 131

EP - 132

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 3

ER -